Diabetes Drugs: Pramlintide :: Diabetes Self-Management
Links shared publicly online about this topic.
- 1,722total visits
Diabetes Drugs: Pramlintide :: Diabetes Self-Management
View full resource at diabetesselfmanagement.com
Tags: Diabetes, Diabetes Medication, Brain, Drug
Most Recently Shared on September 25, 2009 at 8:51 pm By:
#diabetes Learn the particulars about pramlintide in the eighth installment of Mark Marino's series on diabetes drugs. http://bit.ly/YABdu
Diabetes Drugs Without a Prescription? :: Diabetes Self-Management
diabetesselfmanagement.com — “The FDA says it is considering allowing over-the-counter sales of drugs for several conditions, including diabetes.” View full resource at diabetesselfmanagement.com
Most Recently Shared on March 14, 2012 at 4:34 pm By:
Diabetes Self-Mgmt Health Site
The FDA says it is considering allowing over-the-counter sales of drugs for several conditions, including #diabetes. http://t.co/kTli4rsK
Could Drug Shortages Hurt Diabetes Care? :: Diabetes Self-Management
diabetesselfmanagement.com — “Shortages of generic drugs are changing the care of people with cancer and hypertension. What's causing these shortages, and will they affect people with diabetes?” View full resource at diabetesselfmanagement.com
Most Recently Shared on November 23, 2011 at 6:22 pm By:
Diabetes Self-Mgmt Health Site
Shortages of drugs are changing the care of people with cancer and hypertension. Will this trend affect #diabetes? http://t.co/yQaIiIYa
Byetta Fights Inflammation, Study Shows :: Diabetes Self-Management
diabetesselfmanagement.com — “The injectable Type 2 diabetes drug Byetta has a strong and rapid anti-inflammatory effect, according to new research from the University of Buffalo....” View full resource at diabetesselfmanagement.com
Most Recently Shared on November 18, 2011 at 8:24 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Byetta fights inflammation, study shows. http://t.co/jfBJay1g
Byetta Approved as Lantus Add-On :: Diabetes Self-Management
diabetesselfmanagement.com — “On October 19, the US Food and Drug Administration (FDA) approved the Type 2 diabetes medicine Byetta (exenatide) as an add-on treatment to Lantus (insulin glargine) in people who have not achieved blood glucose control with Lantus, diet, and exercise alone...” View full resource at diabetesselfmanagement.com
Most Recently Shared on November 4, 2011 at 3:28 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Byetta has been approved by the FDA as an add-on to Lantus: http://t.co/bu1TmT5z
Type 2 Diabetes Drugs (Page 1) :: Diabetes Self-Management
diabetesselfmanagement.com — “In recent years, the number of medicines approved to treat Type 2 diabetes has grown at an amazing rate. To help you get a handle on this, this article briefly reviews all drugs currently approved in the United States for the treatment of Type 2 diabetes...” View full resource at diabetesselfmanagement.com
Most Recently Shared on August 24, 2011 at 4:49 pm By:
Diabetes Self-Mgmt Health Site
The list of options for treating Type 2 #diabetes is growing. http://t.co/jX39dE5
Mail-Order Meds :: Diabetes Self-Management
diabetesselfmanagement.com — “A new study shows that getting prescription drugs in the mail raises the chances of taking them as directed. Are mail-order pharmacies the way to go?” View full resource at diabetesselfmanagement.com
Most Recently Shared on August 24, 2011 at 4:48 pm By:
Diabetes Self-Mgmt Health Site
#diabetes A new study shows that getting prescription drugs in the mail raises the chances of taking them as directed. http://t.co/SEIbcVG
Health vs. Money :: Diabetes Self-Management
diabetesselfmanagement.com — “A new study shows that lifestyle programs prevent diabetes better than drugs, but cost more than they save. What should insurance companies pay for?” View full resource at diabetesselfmanagement.com
Most Recently Shared on July 13, 2011 at 7:33 pm By:
Diabetes Self-Mgmt Health Site
A new study shows that lifestyle programs prevent #diabetes better than drugs, but cost more than they save. http://t.co/DTcMPbT
Amylin Pharmaceuticals To Present Promising New Data On The Company's Diabetes Programs At ADA 2011
medicalnewstoday.com — “Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) announced that the Company will present data for its two first-in-class diabetes drugs, BYETTA® (exenatide) injection and SYMLIN® (pramlintide a” View full resource at medicalnewstoday.com
Most Recently Shared on June 21, 2011 at 7:05 am By:
MNT Pharma News Health News and Pharma
Amylin Pharmaceuticals To Present Promising New Data On The Company's Diabetes Programs At ADA 2011 http://mnt.to/3XqW
Common Drug Combo Raises Blood Glucose :: Diabetes Self-Management
diabetesselfmanagement.com — “Researchers have discovered that the commonly used combination of two drugs — the antidepressant paroxetine (brand name Paxil) and the cholesterol-lowering medicine pravastatin (Pravachol) — can cause unexpected increases in blood glucose levels, even though neither medicine has this effect when taken alone...” View full resource at diabetesselfmanagement.com
Most Recently Shared on June 10, 2011 at 8:21 pm By:
Diabetes Self-Mgmt Health Site
#diabetes Researchers have found that a common drug combo raises blood glucose: http://t.co/fraMNiO
Old vs. New :: Diabetes Self-Management
diabetesselfmanagement.com — “Diabetes-related spending has increased rapidly in the last decade, with little evidence of a corresponding benefit. For physical and fiscal health, are older drugs the answer?” View full resource at diabetesselfmanagement.com
Most Recently Shared on June 1, 2011 at 6:10 pm By:
Diabetes Self-Mgmt Health Site
#Diabetes-related spending has increased rapidly in the last decade, with little evidence of a corresponding benefit. http://bit.ly/mdoSsn
Researchers seek to determine if combination of two type 1 diabetes medications will work
endocrineweb.com — “A new study on the possibility of combining injections of insulin and the blood sugar-mediating drug pramlintide could help individuals with type 1 diabetes limit the number of injections they need to take each day.Currently, pramlintide is not approved for use in combination with insulin.” View full resource at endocrineweb.com
Most Recently Shared on May 12, 2011 at 9:45 pm By:
JDRF International Health Organization
Researchers seek to determine if a combination of two type 1 #diabetes medications will work. Via Endocrine Web. #JDRF http://ow.ly/4Tqj6
Researchers seek to determine if combination of two type 1 diabetes medications will work
endocrineweb.com — “A new study on the possibility of combining injections of insulin and the blood sugar-mediating drug pramlintide could help individuals with type 1 diabetes limit the number of injections they need to take each day.Currently, pramlintide is not approved for use in combination with insulin.” View full resource at endocrineweb.com
Most Recently Shared on May 12, 2011 at 11:17 am By:
Researchers seek to determine if combination of two type 1 diabetes medications will work http://dlvr.it/RSPd8
Researchers seek to determine if combination of two type 1 diabetes medications will work
endocrineweb.com — “A new study on the possibility of combining injections of insulin and the blood sugar-mediating drug pramlintide could help individuals with type 1 diabetes limit the number of injections they need to take each day.Currently, pramlintide is not approved for use in combination with insulin.” View full resource at endocrineweb.com
Most Recently Shared on May 11, 2011 at 11:40 pm By:
Researchers seek to determine if combination of two type 1 diabetes medications will work: A new study on the po... http://bit.ly/lU9KG0
Drug Marketing in Court :: Diabetes Self-Management
diabetesselfmanagement.com — “Last week, the Supreme Court heard arguments on a Vermont law that denies drug companies records of doctors' prescribing habits. Which side is right?” View full resource at diabetesselfmanagement.com
Most Recently Shared on May 4, 2011 at 8:09 pm By:
Diabetes Self-Mgmt Health Site
Last week, the Supreme Court heard arguments on a law that denies drug companies records of prescribing habits. http://bit.ly/j8NYu3
Disappointing Results for Investigational Type 1 Drug :: Diabetes Self-Management
diabetesselfmanagement.com — “On March 11, drug manufacturer GlaxoSmithKline and biotechnology firm Tolerx announced that their investigational diabetes drug otelixizumab had failed to preserve beta-cell function in people with Type 1 diabetes in a late-stage clinical trial known as DEFEND-1...” View full resource at diabetesselfmanagement.com
Most Recently Shared on March 18, 2011 at 8:36 pm By:
Diabetes Self-Mgmt Health Site
GSK and Tolerx have announced disappointing results for their investigational Type 1 #diabetes drug. http://bit.ly/eT8j8R
Advertisement
